Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 10:02 PM
Study NCT ID:
NCT03418558
Status:
UNKNOWN
Last Update Posted:
2018-10-31
First Post:
2018-01-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.
Sponsor:
Fondazione del Piemonte per l'Oncologia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-08
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-06
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-24
First Submit QC Date:
None
Study First Post Date:
2018-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-29
Last Update Post Date:
2018-10-31
Last Update Post Date Type:
ACTUAL